Published in Lancet on September 11, 1982
Kawasaki disease: recent advances. Arch Dis Child (1991) 2.30
Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia. Emerg Infect Dis (2001) 1.80
Kawasaki syndrome. Clin Microbiol Rev (1998) 1.28
Compliance assessed by the Medication Event Monitoring System. Arch Dis Child (1991) 1.15
Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med (2011) 1.08
Kawasaki syndrome. Br Med J (Clin Res Ed) (1984) 1.06
Finding Kawasaki disease. Ann Pediatr Cardiol (2012) 0.79
Chronic fatigue syndrome: a working case definition. Ann Intern Med (1988) 9.12
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis (1998) 8.51
The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health (1997) 7.81
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med (1983) 6.67
Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet (1975) 6.25
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol (1994) 5.17
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A (1994) 4.86
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
The impact of influenza epidemics on hospitalizations. J Infect Dis (2000) 4.28
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol (1979) 3.36
Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg (1979) 3.23
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med (1984) 3.22
Reye's syndrome in the United States from 1981 through 1997. N Engl J Med (1999) 3.20
Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med (1992) 3.08
Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. JAMA (1993) 2.99
Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA (2000) 2.89
Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet (1989) 2.86
Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet (1974) 2.67
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Prevalence of the human immunodeficiency virus among university students. N Engl J Med (1990) 2.62
Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg (1988) 2.57
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J (1998) 2.53
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun (1977) 2.39
Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol (1985) 2.31
A waterborne outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent. Lancet (1979) 2.29
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Pandemic influenza--including a risk assessment of H5N1. Rev Sci Tech (2009) 2.27
Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. J Pediatr (1996) 2.26
Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA (1996) 2.26
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Science (1994) 2.16
Gamma globulin re-treatment in Kawasaki disease. J Pediatr (1993) 2.13
Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 2.09
Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA (2000) 2.09
Epidemic dengue fever in Puerto Rico, 1977: a cost analysis. Am J Trop Med Hyg (1979) 2.08
Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol (1996) 2.08
Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre. Lancet (1981) 1.99
A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr Res (1976) 1.96
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Severe streptococcal infections in historical perspective. Clin Infect Dis (1992) 1.93
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis (1977) 1.84
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med (1994) 1.79
Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics (1987) 1.76
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol (1994) 1.70
Outbreak of paralytic poliomyelitis, Taiwan. Lancet (1984) 1.68
Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J (1989) 1.67
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr (1991) 1.60
Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes. Am J Trop Med Hyg (1986) 1.56
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Vaccine-associated poliomyelitis in the United States, 1961-1972. Am J Epidemiol (1976) 1.54
Public Health Service study on Reye's syndrome and medications. Report of the pilot phase. N Engl J Med (1985) 1.54
National surveillance of Kawasaki disease. Pediatrics (1980) 1.53
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Epidemiology of cytomegaloviral infections: recommendations for prevention and control. Rev Infect Dis (1985) 1.51
Gastroenteritis due to Norwalk virus: an outbreak associated with a municipal water system. J Infect Dis (1982) 1.49
Public Health Service study of Reye's syndrome and medications. Report of the main study. JAMA (1987) 1.47
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
An outbreak of acute nonbacterial gastroenteritis in a nursing home. Demonstration of person-to-person transmission by temporal clustering of cases. Am J Epidemiol (1982) 1.46
AIDS in children: a review of the clinical, epidemiologic and public health aspects. Pediatr Infect Dis (1985) 1.45
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest (1987) 1.45
An outbreak of Hemophilus influenzae type b meningitis in an enclosed hospital population. J Pediatr (1976) 1.44
The infant rat as a model of bacterial meningitis. J Infect Dis (1977) 1.44
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
Trends in infectious disease hospitalizations among American Indians and Alaska Natives. Am J Public Health (2001) 1.41
Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. Public Health Rep (1993) 1.40
Changing epidemiology of Reye syndrome in the United States. Pediatrics (1986) 1.39
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child (1984) 1.38
Kawasaki disease in healthy young adult. Ann Intern Med (1980) 1.37
Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc Natl Acad Sci U S A (1998) 1.37
Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. J Infect Dis (1979) 1.35
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr (1986) 1.34
Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis (1999) 1.32
Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis (1988) 1.31
Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology (1992) 1.30
Pregnancy-associated deaths due to AIDS in the United States. JAMA (1989) 1.30
Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J (2000) 1.29
Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA (1991) 1.28
Current poliomyelitis immunization policy in the United States. Pediatr Ann (1990) 1.28
Guillain-Barré syndrome and the 1978-1979 influenza vaccine. N Engl J Med (1981) 1.26